世界のイブルチニブAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Ibrutinib API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1346 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はイブルチニブAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。イブルチニブAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（イブルチニブカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・イブルチニブAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・イブルチニブAPIの種類別市場規模：純度≥98％、純度<98％ ・イブルチニブAPIの用途別市場規模：イブルチニブカプセル、その他 ・北米のイブルチニブAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのイブルチニブAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのイブルチニブAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のイブルチニブAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのイブルチニブAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Teva API、Shilpa Medicare Limited、Wisdom Pharmaceutical Co., Ltd.、ScinoPharm Taiwan, Ltd、Sun Pharmaceutical Industries Ltd.、Haoyuan Chemexpress ・イブルチニブAPIのバリューチェーン・販売チャネル分析 ・イブルチニブAPIの世界市場動向

Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.

Market Analysis and Insights: Global Ibrutinib API Market
The global Ibrutinib API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Ibrutinib API Scope and Segment
Ibrutinib API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ibrutinib API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Ibrutinib Capsules Others By Company Dr. Reddy’s Laboratories Ltd. Teva API Shilpa Medicare Limited Wisdom Pharmaceutical Co., Ltd. ScinoPharm Taiwan, Ltd Sun Pharmaceutical Industries Ltd. Haoyuan Chemexpress Production by Region India Israel China Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Ibrutinib API Product Introduction
1.2 Market by Type
1.2.1 Global Ibrutinib API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Ibrutinib API Market Size Growth Rate by Application 1.3.2 Ibrutinib Capsules 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Ibrutinib API Production 2.1 Global Ibrutinib API Production Capacity (2016-2027) 2.2 Global Ibrutinib API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Ibrutinib API Production by Region 2.3.1 Global Ibrutinib API Historic Production by Region (2016-2021) 2.3.2 Global Ibrutinib API Forecasted Production by Region (2022-2027) 2.4 India 2.5 Israel 2.6 China 3 Global Ibrutinib API Sales in Volume & Value Estimates and Forecasts 3.1 Global Ibrutinib API Sales Estimates and Forecasts 2016-2027 3.2 Global Ibrutinib API Revenue Estimates and Forecasts 2016-2027 3.3 Global Ibrutinib API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Ibrutinib API Regions by Sales 3.4.1 Global Top Ibrutinib API Regions by Sales (2016-2021) 3.4.2 Global Top Ibrutinib API Regions by Sales (2022-2027) 3.5 Global Top Ibrutinib API Regions by Revenue 3.5.1 Global Top Ibrutinib API Regions by Revenue (2016-2021) 3.5.2 Global Top Ibrutinib API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Ibrutinib API Production Capacity by Manufacturers 4.2 Global Ibrutinib API Sales by Manufacturers 4.2.1 Global Top Ibrutinib API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Ibrutinib API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Ibrutinib API Sales in 2020 4.3 Global Ibrutinib API Revenue by Manufacturers 4.3.1 Global Top Ibrutinib API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Ibrutinib API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Ibrutinib API Revenue in 2020 4.4 Global Ibrutinib API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Ibrutinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Ibrutinib API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Ibrutinib API Sales by Type 5.1.1 Global Ibrutinib API Historical Sales by Type (2016-2021) 5.1.2 Global Ibrutinib API Forecasted Sales by Type (2022-2027) 5.1.3 Global Ibrutinib API Sales Market Share by Type (2016-2027) 5.2 Global Ibrutinib API Revenue by Type 5.2.1 Global Ibrutinib API Historical Revenue by Type (2016-2021) 5.2.2 Global Ibrutinib API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Ibrutinib API Revenue Market Share by Type (2016-2027) 5.3 Global Ibrutinib API Price by Type 5.3.1 Global Ibrutinib API Price by Type (2016-2021) 5.3.2 Global Ibrutinib API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Ibrutinib API Sales by Application 6.1.1 Global Ibrutinib API Historical Sales by Application (2016-2021) 6.1.2 Global Ibrutinib API Forecasted Sales by Application (2022-2027) 6.1.3 Global Ibrutinib API Sales Market Share by Application (2016-2027) 6.2 Global Ibrutinib API Revenue by Application 6.2.1 Global Ibrutinib API Historical Revenue by Application (2016-2021) 6.2.2 Global Ibrutinib API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Ibrutinib API Revenue Market Share by Application (2016-2027) 6.3 Global Ibrutinib API Price by Application 6.3.1 Global Ibrutinib API Price by Application (2016-2021) 6.3.2 Global Ibrutinib API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Ibrutinib API Market Size by Type 7.1.1 North America Ibrutinib API Sales by Type (2016-2027) 7.1.2 North America Ibrutinib API Revenue by Type (2016-2027) 7.2 North America Ibrutinib API Market Size by Application 7.2.1 North America Ibrutinib API Sales by Application (2016-2027) 7.2.2 North America Ibrutinib API Revenue by Application (2016-2027) 7.3 North America Ibrutinib API Sales by Country 7.3.1 North America Ibrutinib API Sales by Country (2016-2027) 7.3.2 North America Ibrutinib API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Ibrutinib API Market Size by Type 8.1.1 Europe Ibrutinib API Sales by Type (2016-2027) 8.1.2 Europe Ibrutinib API Revenue by Type (2016-2027) 8.2 Europe Ibrutinib API Market Size by Application 8.2.1 Europe Ibrutinib API Sales by Application (2016-2027) 8.2.2 Europe Ibrutinib API Revenue by Application (2016-2027) 8.3 Europe Ibrutinib API Sales by Country 8.3.1 Europe Ibrutinib API Sales by Country (2016-2027) 8.3.2 Europe Ibrutinib API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Ibrutinib API Market Size by Type 9.1.1 Asia Pacific Ibrutinib API Sales by Type (2016-2027) 9.1.2 Asia Pacific Ibrutinib API Revenue by Type (2016-2027) 9.2 Asia Pacific Ibrutinib API Market Size by Application 9.2.1 Asia Pacific Ibrutinib API Sales by Application (2016-2027) 9.2.2 Asia Pacific Ibrutinib API Revenue by Application (2016-2027) 9.3 Asia Pacific Ibrutinib API Sales by Region 9.3.1 Asia Pacific Ibrutinib API Sales by Region (2016-2027) 9.3.2 Asia Pacific Ibrutinib API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Ibrutinib API Market Size by Type 10.1.1 Latin America Ibrutinib API Sales by Type (2016-2027) 10.1.2 Latin America Ibrutinib API Revenue by Type (2016-2027) 10.2 Latin America Ibrutinib API Market Size by Application 10.2.1 Latin America Ibrutinib API Sales by Application (2016-2027) 10.2.2 Latin America Ibrutinib API Revenue by Application (2016-2027) 10.3 Latin America Ibrutinib API Sales by Country 10.3.1 Latin America Ibrutinib API Sales by Country (2016-2027) 10.3.2 Latin America Ibrutinib API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Ibrutinib API Market Size by Type 11.1.1 Middle East and Africa Ibrutinib API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Ibrutinib API Revenue by Type (2016-2027) 11.2 Middle East and Africa Ibrutinib API Market Size by Application 11.2.1 Middle East and Africa Ibrutinib API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Ibrutinib API Revenue by Application (2016-2027) 11.3 Middle East and Africa Ibrutinib API Sales by Country 11.3.1 Middle East and Africa Ibrutinib API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Ibrutinib API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Ibrutinib API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Teva API 12.2.1 Teva API Corporation Information 12.2.2 Teva API Overview 12.2.3 Teva API Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Teva API Ibrutinib API Product Description 12.2.5 Teva API Recent Developments 12.3 Shilpa Medicare Limited 12.3.1 Shilpa Medicare Limited Corporation Information 12.3.2 Shilpa Medicare Limited Overview 12.3.3 Shilpa Medicare Limited Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Shilpa Medicare Limited Ibrutinib API Product Description 12.3.5 Shilpa Medicare Limited Recent Developments 12.4 Wisdom Pharmaceutical Co., Ltd. 12.4.1 Wisdom Pharmaceutical Co., Ltd. Corporation Information 12.4.2 Wisdom Pharmaceutical Co., Ltd. Overview 12.4.3 Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Product Description 12.4.5 Wisdom Pharmaceutical Co., Ltd. Recent Developments 12.5 ScinoPharm Taiwan, Ltd 12.5.1 ScinoPharm Taiwan, Ltd Corporation Information 12.5.2 ScinoPharm Taiwan, Ltd Overview 12.5.3 ScinoPharm Taiwan, Ltd Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 ScinoPharm Taiwan, Ltd Ibrutinib API Product Description 12.5.5 ScinoPharm Taiwan, Ltd Recent Developments 12.6 Sun Pharmaceutical Industries Ltd. 12.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information 12.6.2 Sun Pharmaceutical Industries Ltd. Overview 12.6.3 Sun Pharmaceutical Industries Ltd. Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Sun Pharmaceutical Industries Ltd. Ibrutinib API Product Description 12.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments 12.7 Haoyuan Chemexpress 12.7.1 Haoyuan Chemexpress Corporation Information 12.7.2 Haoyuan Chemexpress Overview 12.7.3 Haoyuan Chemexpress Ibrutinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Haoyuan Chemexpress Ibrutinib API Product Description 12.7.5 Haoyuan Chemexpress Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Ibrutinib API Industry Chain Analysis 13.2 Ibrutinib API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Ibrutinib API Production Mode & Process 13.4 Ibrutinib API Sales and Marketing 13.4.1 Ibrutinib API Sales Channels 13.4.2 Ibrutinib API Distributors 13.5 Ibrutinib API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Ibrutinib API Industry Trends 14.2 Ibrutinib API Market Drivers 14.3 Ibrutinib API Market Challenges 14.4 Ibrutinib API Market Restraints 15 Key Finding in The Global Ibrutinib API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Ibrutinib API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Ibrutinib API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Ibrutinib API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Ibrutinib API Production by Region (2016-2021) & (Ton)
Table 7. Global Ibrutinib API Production Market Share by Region (2016-2021)
Table 8. Global Ibrutinib API Production by Region (2022-2027) & (Ton)
Table 9. Global Ibrutinib API Production Market Share by Region (2022-2027)
Table 10. Global Ibrutinib API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Ibrutinib API Sales by Region (2016-2021) & (Ton)
Table 12. Global Ibrutinib API Sales Market Share by Region (2016-2021)
Table 13. Global Ibrutinib API Sales by Region (2022-2027) & (Ton)
Table 14. Global Ibrutinib API Sales Market Share by Region (2022-2027)
Table 15. Global Ibrutinib API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Ibrutinib API Revenue Market Share by Region (2016-2021)
Table 17. Global Ibrutinib API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Ibrutinib API Revenue Market Share by Region (2022-2027)
Table 19. Global Ibrutinib API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Ibrutinib API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Ibrutinib API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Ibrutinib API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Ibrutinib API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Ibrutinib API Sales Share by Manufacturers (2016-2021)
Table 25. Global Ibrutinib API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Ibrutinib API Revenue Share by Manufacturers (2016-2021)
Table 27. Ibrutinib API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Ibrutinib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Ibrutinib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ibrutinib API as of 2020)
Table 30. Ibrutinib API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Ibrutinib API Product Offered
Table 32. Date of Manufacturers Enter into Ibrutinib API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 35. Global Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 36. Global Ibrutinib API Sales Share by Type (2016-2021)
Table 37. Global Ibrutinib API Sales Share by Type (2022-2027)
Table 38. Global Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Ibrutinib API Revenue Share by Type (2016-2021)
Table 41. Global Ibrutinib API Revenue Share by Type (2022-2027)
Table 42. Ibrutinib API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Ibrutinib API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 45. Global Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 46. Global Ibrutinib API Sales Share by Application (2016-2021)
Table 47. Global Ibrutinib API Sales Share by Application (2022-2027)
Table 48. Global Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Ibrutinib API Revenue Share by Application (2016-2021)
Table 51. Global Ibrutinib API Revenue Share by Application (2022-2027)
Table 52. Ibrutinib API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Ibrutinib API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 55. North America Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 56. North America Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 59. North America Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 60. North America Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Ibrutinib API Sales by Country (2016-2021) & (Ton)
Table 63. North America Ibrutinib API Sales by Country (2022-2027) & (Ton)
Table 64. North America Ibrutinib API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Ibrutinib API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Ibrutinib API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Ibrutinib API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Ibrutinib API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Ibrutinib API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Ibrutinib API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Ibrutinib API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Ibrutinib API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Ibrutinib API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Ibrutinib API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Ibrutinib API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Ibrutinib API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Ibrutinib API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Ibrutinib API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Ibrutinib API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Ibrutinib API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Ibrutinib API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Ibrutinib API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Ibrutinib API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Ibrutinib API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Ibrutinib API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Ibrutinib API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Ibrutinib API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Ibrutinib API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Ibrutinib API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Teva API Corporation Information
Table 120. Teva API Description and Major Businesses
Table 121. Teva API Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Teva API Ibrutinib API Product
Table 123. Teva API Recent Development
Table 124. Shilpa Medicare Limited Corporation Information
Table 125. Shilpa Medicare Limited Description and Major Businesses
Table 126. Shilpa Medicare Limited Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Shilpa Medicare Limited Ibrutinib API Product
Table 128. Shilpa Medicare Limited Recent Development
Table 129. Wisdom Pharmaceutical Co., Ltd. Corporation Information
Table 130. Wisdom Pharmaceutical Co., Ltd. Description and Major Businesses
Table 131. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Product
Table 133. Wisdom Pharmaceutical Co., Ltd. Recent Development
Table 134. ScinoPharm Taiwan, Ltd Corporation Information
Table 135. ScinoPharm Taiwan, Ltd Description and Major Businesses
Table 136. ScinoPharm Taiwan, Ltd Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. ScinoPharm Taiwan, Ltd Ibrutinib API Product
Table 138. ScinoPharm Taiwan, Ltd Recent Development
Table 139. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 140. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 141. Sun Pharmaceutical Industries Ltd. Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Sun Pharmaceutical Industries Ltd. Ibrutinib API Product
Table 143. Sun Pharmaceutical Industries Ltd. Recent Development
Table 144. Haoyuan Chemexpress Corporation Information
Table 145. Haoyuan Chemexpress Description and Major Businesses
Table 146. Haoyuan Chemexpress Ibrutinib API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Haoyuan Chemexpress Ibrutinib API Product
Table 148. Haoyuan Chemexpress Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Ibrutinib API Distributors List
Table 152. Ibrutinib API Customers List
Table 153. Ibrutinib API Market Trends
Table 154. Ibrutinib API Market Drivers
Table 155. Ibrutinib API Market Challenges
Table 156. Ibrutinib API Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Ibrutinib API Product Picture
Figure 2. Global Ibrutinib API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Ibrutinib API Market Share by Application in 2020 & 2027
Figure 6. Ibrutinib Capsules
Figure 7. Others
Figure 8. Ibrutinib API Report Years Considered
Figure 9. Global Ibrutinib API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Ibrutinib API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Ibrutinib API Production Market Share by Region (2016-2021)
Figure 12. Global Ibrutinib API Production Market Share by Region (2022-2027)
Figure 13. Ibrutinib API Production Growth Rate in India (2016-2027) & (Ton)
Figure 14. Ibrutinib API Production Growth Rate in Israel (2016-2027) & (Ton)
Figure 15. Ibrutinib API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Global Ibrutinib API Sales 2016-2027 (Ton)
Figure 17. Global Ibrutinib API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Ibrutinib API Revenue 2016-2027 (US$ Million)
Figure 19. Global Ibrutinib API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 20. Global Ibrutinib API Sales Market Share by Region (2016-2021)
Figure 21. Global Ibrutinib API Sales Market Share by Region (2022-2027)
Figure 22. North America Ibrutinib API Sales YoY (2016-2027) & (Ton)
Figure 23. North America Ibrutinib API Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Europe Ibrutinib API Sales YoY (2016-2027) & (Ton)
Figure 25. Europe Ibrutinib API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Asia-Pacific Ibrutinib API Sales YoY (2016-2027) & (Ton)
Figure 27. Asia-Pacific Ibrutinib API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Latin America Ibrutinib API Sales YoY (2016-2027) & (Ton)
Figure 29. Latin America Ibrutinib API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Middle East & Africa Ibrutinib API Sales YoY (2016-2027) & (Ton)
Figure 31. Middle East & Africa Ibrutinib API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Ibrutinib API Sales in 2020
Figure 33. The Top 10 and Top 5 Players Market Share by Ibrutinib API Revenue in 2020
Figure 34. Ibrutinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Global Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 36. Global Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 37. Global Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 38. Global Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 39. North America Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 40. North America Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 41. North America Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 42. North America Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 43. North America Ibrutinib API Sales Share by Country (2016-2027)
Figure 44. North America Ibrutinib API Revenue Share by Country (2016-2027)
Figure 45. United States Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 46. Canada Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 47. Europe Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 48. Europe Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 49. Europe Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 50. Europe Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 51. Europe Ibrutinib API Sales Share by Country (2016-2027)
Figure 52. Europe Ibrutinib API Revenue Share by Country (2016-2027)
Figure 53. Germany Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 54. France Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 55. U.K. Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 56. Italy Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 57. Russia Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 58. Asia Pacific Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 59. Asia Pacific Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 60. Asia Pacific Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 61. Asia Pacific Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 62. Asia Pacific Ibrutinib API Sales Share by Region (2016-2027)
Figure 63. Asia Pacific Ibrutinib API Revenue Share by Region (2016-2027)
Figure 64. China Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 65. Japan Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 66. South Korea Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 67. India Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 68. Australia Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 69. China Taiwan Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 70. Indonesia Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 71. Thailand Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 72. Malaysia Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 73. Latin America Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 74. Latin America Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 75. Latin America Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 76. Latin America Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 77. Latin America Ibrutinib API Sales Share by Country (2016-2027)
Figure 78. Latin America Ibrutinib API Revenue Share by Country (2016-2027)
Figure 79. Mexico Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 80. Brazil Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 81. Argentina Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Ibrutinib API Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Ibrutinib API Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Ibrutinib API Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Ibrutinib API Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Ibrutinib API Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Ibrutinib API Revenue Share by Country (2016-2027)
Figure 88. Turkey Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Ibrutinib API Revenue (2016-2027) & (US$ Million)
Figure 91. Ibrutinib API Value Chain
Figure 92. Ibrutinib API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---